Why It Matters
Procter & Gamble Co. is lobbying on the PACK Act (H.R. 6832, Packaging and Claims Knowledge Act). The filing also lists issues related to FDA review of active ingredients in over-the-counter (OTC) products.
By the Numbers
The third-quarter 2026 report from Procter & Gamble Co. lists a filing amount of $350,000. Across all five registrants, P&G's third-quarter 2026 total is $490,000, down $361,000 from the second-quarter 2026 cross-registrant total of $851,000.
Outside firms and third-quarter fees: Harbinger Strategies LLC: $50,000; BGR Government Affairs LLC: $60,000; Ridgeline Advocacy Group LLC: $0; Washington Tax and Public Policy Group LLC: $30,000.
The in-house filing names four lobbyists: Tara Hogan Charles, Robert Cusmano, Matt Bisenius, and Christina Lotspike. Cusmano previously served as a legislative assistant on the House Ways and Means Committee in December 2016, and later as tax counsel to Rep. Tom Rice and Sen. Rob Portman. Bisenius previously served in the office of former Rep. Jim Sensenbrenner (R-WI-5).
Broader Context
H.R. 6832, the Packaging and Claims Knowledge Act (PACK Act), was introduced by Rep. Randy K. Weber, Sr. (R-TX-14) and referred to the House Committee on Energy and Commerce on Dec. 17, 2025. Rep. Weber said the bill would replace varying state packaging-claim rules with a uniform federal framework; co-sponsor Rep. Russ Fulcher said it would reduce confusion and lower costs. Supporters include the U.S. Chamber of Commerce, National Association of Manufacturers, Consumer Brands Association, General Mills, Kraft Heinz, PepsiCo, Nestlé USA, Keurig Dr Pepper, and McCormick & Company. Opponents, including Moms Clean Air Force and the Natural Resources Defense Council, argued the bill would preempt state truth-in-labeling laws and risk sending unrecyclable plastic into recycling streams.
FDA issued a final order in June allowing bemotrizinol in sunscreen products and in July published a procedure for data requests to inform OTC monograph activities. In a comment to FDA, P&G stated it supported improving OTC drug regulation while preserving the existing OTC monograph review framework.
H.R. 1 became Public Law 119-21; Congressional Research Service (CRS) analysis states its international tax changes generally take effect for tax years beginning after Dec. 31, 2025. The Senate Environment and Public Works Committee held a legislative hearing March 4 on a discussion draft of the Toxic Substances Control Act (TSCA) Fee Reauthorization and Improvement Act of 2026, addressing EPA's review of new chemicals.
Competitive Landscape
Other organizations lobbying H.R. 6832 include ABB Inc., Keurig Dr Pepper Inc., Personal Care Products Council, PepsiCo Inc., and Lenovo (United States) Inc.
The Bottom Line
H.R. 6832, the PACK Act, is in committee: its latest recorded action is referral to the House Committee on Energy and Commerce. Across complete quarters, the in-house team contracted from eight lobbyists in the third quarter of 2025 to four in the third quarter of 2026, with the cross-registrant fee total falling from $971,000 to $490,000 over the same period.
Access the Legis1 platform for comprehensive political news, data, and insights
Spot something wrong? Report an issue with this article
